International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 1159

PDF Downloaded: 731


Get Permission Manohari and Pathan: Evaluation of thyroid profile and renal function tests in chronic kidney disease patients


Introduction

In Chronic kidney disease (CKD), an irreversible deterioration in renal function occurs that classically develops over a period of years. It is defined as abnormalities of renal function and or structure lasting for 3 or more months having several health implications. It eventually lands up in the loss of excretory, metabolic and endocrine functioning of the kidneys. This impaired renal function results in the development of the clinical symptoms and signs which are referred to as uremia. If these subjects are not diagnosed at an early stage and remain untreated without renal replacement therapy, the disease progress to End stage renal failure with poor outcome in terms of morbidity and mortality. Patients with CKD frequently present with signs & symptoms suggestive of thyroid dysfunctions. Previous literature about studies of assessment of functioning of thyroid in CKD patients reports conflicting results. Present study was planned to estimate the thyroid hormones T3, T4 and TSH, Blood urea and Serum Creatinine in cases with CKD and controls.

Materials and Methods

In this case control study which was done from January to June 2015. All diagnosed CKD patients attending Nephrology Department and Dialysis unit in King George hospital, Visakhapatnam were included in the study. The study comprised of 37 diagnosed cases of CKD and 30 healthy age and sex matched controls to evaluate the thyroid hormone profile and renal function tests. The study protocol had been approved by the Institutional Ethics committee and written informed consents were obtained by all participants.

Inclusion criteria

All patients aged 40 to 70 years defined as case of chronic kidney disease by nephrology department were included in the study.

Case of CKD was defined as eGFR ≥ 90 mL/min/1.73m 2 with abnormal urine and blood chemistry, persistent proteinuria or abnormal imaging studies of the kidney or eGFR ≤ 90 mL/min/1.73m 2 The eGFR was done using the 4v-MDRD formula.1

Controls included 30 Healthy age and sex matched subjects aged between 40 -70 years.

Exclusion criteria

Patients with diabetic nephropathy, major diseases like malignancy, cardiovascular diseases were excluded. Patients receiving hormone replacement therapy, corticosteroids, sulphonylureas and phenobarbitones, were not included in the study.

Sample collection

After overnight fast, morning blood samples were collected and allowed to clot. Serum was separated by centrifugation and analyzed for thyroid hormone profile and renal function tests.

Blood urea estimation

Blood urea was estimated by Urease method2 using fully automated Cobas C311 chemistry analyser.

Estimation of Serum Creatinine by Modified Jaffe's method

Creatinine concentration in blood samples were assayed by Jaffe Kinetic method.3

Estimation of T3, T4 & TSH levels by Chemiluminescence immunoassay (CLIA)

Thyroid hormones were estimated using Chemiluminescence immunoassay technique in which principle & procedure for estimation of serum T3 & T4 hormones are similar. This assay is based on a competitive test principle in which polyclonal antibodies are specially directed against T3 T4 and TSH.

Results

Mean blood urea levels among cases was 108.92 ±52.19 (mg%) and in controls was 28.47±8.40 (mg%) with p value <0.01 which was statistically significant. Mean value of Serum creatinine in cases group was 5.64±2.97 (mg%) and in controls 1.09±0.17 (mg %) and p value was <0.01 which was statistically significant. Mean value of serum T3 concentration among cases group is 86.92±0.23 (ng /dl) and in controls is 111.96±10.17 (ng/dl). It means T3 was decreased in cases as compared to controls with p value <0.01 which was statistically significant. Mean value of T4 among cases was 7.27 (µg/dl) ± 2.19 in comparison to controls 8.36 (µg/dl) ± 0.46 and p value was > 0.01 which was not statistically significant

Mean TSH concentration in cases group was 3.88 (µIU /ml) ± 2.09 which was increased when compared to controls 3.02 (µIU /ml) ±0. 79; P value >0.01 which was not statistically significant.

Among 37 cases, 6 patients (16.2%) have T3, T4 levels below normal range and TSH above the normal range suggestive of hypothyroid state and remaining 31 patients (83.8%) were in euthyroid state. In case group, 27 cases of CKD were managed without dialysis and 10 patients of CKD were on hemodialysis. 3(11%) out of 27 CKD patients without hemodialysis were hypothyroid and 3(30%) out of 10 CKD patients, on hemodialysis were hypothyroid. Thus, we observed decreased levels of T3, T4 increased TSH along with increased serum creatinine levels. The incidence of hypothyroidism was observed to be 16.2% in cases group in comparison to control group.

Table 1
Age in years Cases n=37 Controls n=30
Number Percentage (%) Number Percentage (%)
44-49 8 21.6 7 23.3
50-54 11 29.7 9 30.0
55-59 10 27 10 33.3
60 & above 8 21.6 4 13.3
Total 37 100.0 30 100.0

Distribution of age (years) of participants between two groups

Table 2
Study variables Cases n=37 Controls n=30 P value
Blood urea (mg/dl) 108.92±52.19 28.47±8.40 <0.01**
Serum creatinine (mg/dl) 5.64±2.97 1.07±0.17 <0.01**
T3 (ng/dl) 86.92± 0.23 111.96±10.17 <0.01**
T4 ( µg/dl) 7.27±2.19 8.36±0.46 >0.01**
TSH ( µIU /ml) 3.88±2.09 3.02±0.79 >0.01**

Comparison of studied biochemical parameters in cases and controls (mean ±SD)

[i] P value >0.01 Not significant; P value < 0.01 significant; P value < 0.001 Highly significant; n- number of study participants

Figure 1

Comparison of Mean values of blood urea incases and controls

https://s3-us-west-2.amazonaws.com/typeset-media-server/62c756b9-dcf1-4b93-8f7b-343dfedc41afimage1.png

Figure 2

Comparison of Mean values of serum creatininein cases and controls

https://s3-us-west-2.amazonaws.com/typeset-media-server/62c756b9-dcf1-4b93-8f7b-343dfedc41afimage2.png

Figure 3

Comparison of Mean values of serum T3 levelsin cases and controls

https://s3-us-west-2.amazonaws.com/typeset-media-server/62c756b9-dcf1-4b93-8f7b-343dfedc41afimage3.png

Figure 4

Comparison of Mean values of serum T4 in casesand controls

https://s3-us-west-2.amazonaws.com/typeset-media-server/62c756b9-dcf1-4b93-8f7b-343dfedc41afimage4.png
Table 3
T3 (ng /dl) Cases Con trols
<60 ng/dl 6(16.2%) 0
60- 200 ng/dl 31(83.8%) 30(100%)
>200 ng/dl 0 0

Comparison of serum T3 levels in cases and controls

Table 4
T4 (µg/dl) Cases Controls
<4.5 (µg/dl) 6(16.2%) 0
4.5 -12.0 (µg/dl) 31(83.8%) 30(100%)
>12.0 (µg/dl) 0 0

Comparison of serum T4 levels in cases and controls

Table 5
TSH (µIU/ml) Cases Controls
<0.30 µIU/ml 0 0
0.30- 5.50 µIU/ml 31(83.8%) 30(100%)
>5.50 µIU/ml 6(16.2%) 0

Comparison of serum TSH levels in cases and controls

Discussion

Mean value of T3 in cases was observed to be decreased significantly (p value <0.01) in comparison to controls even though most of them are within the normal range. Presence of altered thyroid hormones profile as either hyperthyroidism or hypothyroidism & euthyroid state have been reported by numerous investigators.8, 7, 6, 5, 4 Consistent low Serum Tri-iodothyronine(T3) levels were observed while serum total and free thyroxine(T4) concentration have been reported as low, normal or high among CKD patients with or without hemodialysis. Serum thyroid stimulating hormone (TSH) levels were reported within normal limits in most of the CKD patients even if with low serum T3 concentration9 One of the possible reasons for altered serum thyroid hormonal levels could be due to the changed binding capacity of serum proteins in CKD due to renal damage. In CKD patients, massive proteinuria occurs that is mainly albuminuria without much changes in Globulin levels. State of Hypothyroidism in CKD is chiefly due to hypoalbuminemia and decreased thyroid binding pre-albumin levels.11, 10 Also raised circulating thyroid binding inhibitors inhibits the binding of thyroid hormones to carrier proteins which may be an additional cause of hypothyroidism in CKD patients.12

Serum TSH levels remain within normal limits in spite of low T3 and T4 concentration. This could not be due to dysfunction in hypothalamo-pitutary axis but because of high TSH response due to hypothyroid state in renal failure patients.12, 9 Few studies reported normal TSH levels due to blunted TSH response to TRH which is suggestive of probability of pituitary dysfunction also.14, 13 Serum thyroid hormone levels depend on the duration of renal failure and its underlying cause. Restoration of normal functioning of kidney resulting in normalization of biochemical parameters of thyroid function with the exception of blunted or absent TSH response to TRH has been reported in patients with CKD after renal transplant. Blunted or absent TSH response to TRH may be a direct consequence of administration of glucocorticoids in these patients. Chronic kidney disease (CKD) patients can be categorized to five stages of kidney damage, from extremely mild stage 1 damage to complete stage 5 kidney failure. In the later stage, the kidneys get contracted. Since last few decades, dramatic increase in the incidence of cases of end stage renal disease has been reported due to altered lifestyle. High prevalence of non-communicable diseases especially Diabetes mellitus and hypertension are responsible for up to two-thirds of cases and other causes include Glomerulonephritis, polycystic kidney disease, malformations, lupus, prostate enlargement. Results of the present study are in accordance with those of previous studies which report decreased levels of T3 in uremia and patients on hemodialysis. 16, 15, 14 Serum total tri-iodothyronine levels were consistently found to be low irrespective of treatment strategy of CKD. Thyroid function studies which were conducted in clinically euthyroid uremic patients demonstrated decrease levels of serum tri-iodothyronine and this reduction in the concentration of T3 has been linked to decrease in peripheral synthesis of T3 from T4. Serum levels of total tri-iodothyronine (T3) in uremic patients is low because source of more than half of the circulating T3 is by peripheral conversion of thyroxine; T4 to T3. Serum T4 levels in cases is apparently decreased compared to the controls, but the difference is not statistically significant. The findings of our study are comparable with those from previous studies. Serum T4 concentration although within the normal range, tend to be lower than in controls are in agreement with the findings of other investigators. The findings of previous studies are conflicting one. Patients with low T3, T4 showed high TSH that suggest maintenance of pituitary thyroid axis. The absence of TSH elevation is generally regarded as an evidence against hypothyroidism state, yet hypothalamo -pituitary dysfunction may also present which can be reflected by the subnormal TSH response to TRH. Thyroid function studies in patients with CKD before & after hemodialysis showed slight increase in T3 concentration without significant change in other thyroid function.19, 18, 17

Among 37 cases; 6 patients (16.2%) we re hypothyroid and remaining 31 patients (83.8%) were euthyroid . Hyperthyroidism was not observed in both groups- cases and controls. All the controls were having euthyroid state. Our study findings are comparable with those of previous studies. CKD is found to be associated with higher prevalence of hypothyroidism, both overt and subclinical, but not with hyperthyroidism. Primary hypothyroidism is mainly in the subclinical form in CKD patients which increases as the glomerular filtration rate (GFR) decreases. The study findings are comparable with the previous study findings that is decreased T3, T4 and increased TSH levels with increased severity of renal damage.22, 21, 20

Conclusion

Serum T3 is decreased in cases group compared to controls and difference is statistically significant whereas T4 and TSH values of cases were not statistically significant when compared with controls. These results points towards the association of low T3 syndrome with CKD. Hyperthyroidism is not observed in both cases & controls groups. TSH increases as T3, T4 decreases suggesting the maintenance of pituitary thyroid axis in this study group. The level of T3, T4 level decreases and TSH increases as severity of renal failure increases (i.e., as serum creatinine increases).

Source of funding

None.

Conflict of interest

None.

References

1 

A S Levey J P Bosch Lewis J B Greene T Rogers N Roth D A more accurate method to estimate glomerular filtration rate from serum creatinineAnn Inter Med1999130461470

2 

R C Rock W G Walker C D Hennings Tietz NW Nitrogen metabolites and renal functionFundamentals of Clinical Chemistry198766970

3 

G M Gonella Effect of dialysis on certain biochemical parameters in chronic renal failure patientsInternational Journal of Contemporary Medical Research2016324547379

4 

P Schmidt N Stobaeus Prame G Schittek F Exopthalmous in chronic renal insufficiencyScand J Urol Nephrol 19715146153

5 

Adrian I. Katz Dimitrios S. Emmanouel Marshall D. Lindheimer Thyroid Hormone and the KidneyNephron1975153-5223249

6 

Yashpal Thyroid function in uremiaInd J Nephrol (New Series)19912211

7 

D A Spector P J Davis J H Helderman Thyroid function and metabolic state in chronic renal failureAnn Int Med197685724730

8 

G Avasthi Malhotra Narang Sengupta Study of thyroid function on of chronic renal failureIndian J Nephro200111165169

9 

G Neuhaus G Baumann A Walter and H Tholen Serum thyroxine and thyroid binding proteins chronic renal failureJ Clin Endocrinol Metabol1975395398

10 

Thyroid function in patients with chronic renal failureAm J Kidney Dis200138IA, USA580584

11 

V S Lim V S Fang A L Katz Refetoffs Thyroid dysfunction in chronic renal failureJ Clin Invest1977663522534

12 

5th edn. Brenner and Rectors: The kidney text book224562457

13 

H J Kohli S K Mahajan O P Karla K C Malhotra Thyroid status in chronic renal failureIndian J Nephrol1993323236

14 

H J Mehta Total free thyroid hormone levels in chronic renal failureJ Postgraduate Med19913727983

15 

H Quion-Verde E M Kaptein C J Choolijan H J Radriquez S G Massary Prevalence of thyroid disease in chronic renal failure(CRF) and dialysis patients9th edn.Congr of Nephrol Los Angeles1984120

16 

E M Kaptein Quion-Verde H C J Chooljian W W Tang P E Friedman The Thyroid in End-Stage Renal DiseaseMed1988673187

17 

E M Kaptein Thyroid Hormone Metabolism and Thyroid Diseases in Chronic Renal FailureEndocrine Reviews19961714563

18 

S Kutty T Atli O Kosiogullari N Duman S Gullu Thyroid disorders in haemodialysis patients in iodine deficient community200529329332

19 

Evidence with thyroid and hypophyseal abnormalitiesAnn Int Med19766728484

20 

N G Desanto R N Fine C Carela Thyroid function in uremic childrenKidney Int198528

21 

J Forest J Dube J Talbot Thyroid hormone in patients with chronic renal failure undergoing maintenance hemodialysisAm J Clin Pathol 198277580

22 

Victoria Sy Lim Victor S. Fang Adrian I. Katz Samuel Refetoff Thyroid Dysfunction in Chronic Renal FailureJournal of Clinical Investigation19776035225340021-973810.1172/jci108804American Society for Clinical Investigationhttps://dx.doi.org/10.1172/jci108804



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

142-146


Authors Details

A L Manohari, Firoz Pathan


Article Metrics


View Article As

 


Downlaod Files